Annual Working Capital
$345.98 M
-$65.01 M-15.82%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual working capital is currently $345.98 million, with the most recent change of -$65.01 million (-15.82%) on 31 December 2023. During the last 3 years, it has fallen by -$116.44 million (-25.18%). BCRX annual working capital is now -25.18% below its all-time high of $462.42 million, reached on 31 December 2021.BCRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$273.56 M
+$39.17 M+16.71%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly working capital is currently $273.56 million, with the most recent change of +$39.17 million (+16.71%) on 30 September 2024. Over the past year, it has dropped by -$72.42 million (-20.93%). BCRX quarterly working capital is now -40.84% below its all-time high of $462.42 million, reached on 31 December 2021.BCRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -20.9% |
| 3 y3 years | -25.2% | -40.8% |
| 5 y5 years | +380.5% | +279.9% |
BCRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -25.2% | at low | -40.8% | +16.7% |
| 5 y | 5 years | -25.2% | +380.5% | -40.8% | +733.8% |
| alltime | all time | -25.2% | >+9999.0% | -40.8% | +2263.4% |
BioCryst Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $273.56 M(+16.7%) |
| June 2024 | - | $234.39 M(-28.4%) |
| Mar 2024 | - | $327.18 M(-5.4%) |
| Dec 2023 | $345.98 M(-15.8%) | $345.98 M(-16.0%) |
| Sept 2023 | - | $411.70 M(-1.4%) |
| June 2023 | - | $417.56 M(+2.9%) |
| Mar 2023 | - | $405.73 M(-1.3%) |
| Dec 2022 | $410.99 M(-11.1%) | $410.99 M(-3.8%) |
| Sept 2022 | - | $427.36 M(+7.0%) |
| June 2022 | - | $399.46 M(-7.3%) |
| Mar 2022 | - | $430.70 M(-6.9%) |
| Dec 2021 | $462.42 M(+112.0%) | $462.42 M(+288.1%) |
| Sept 2021 | - | $119.14 M(-20.7%) |
| June 2021 | - | $150.20 M(-13.0%) |
| Mar 2021 | - | $172.57 M(-20.9%) |
| Dec 2020 | $218.15 M(+202.9%) | $218.15 M(+330.6%) |
| Sept 2020 | - | $50.66 M(-49.9%) |
| June 2020 | - | $101.19 M(+208.4%) |
| Mar 2020 | - | $32.81 M(-54.4%) |
| Dec 2019 | $72.01 M(+60.5%) | $72.01 M(-2239.3%) |
| Sept 2019 | - | -$3.37 M(-110.6%) |
| June 2019 | - | $31.77 M(-38.1%) |
| Mar 2019 | - | $51.32 M(+14.4%) |
| Dec 2018 | $44.88 M(-11.2%) | $44.88 M(-30.0%) |
| Sept 2018 | - | $64.14 M(+246.8%) |
| June 2018 | - | $18.50 M(-35.8%) |
| Mar 2018 | - | $28.81 M(-43.0%) |
| Dec 2017 | $50.55 M(+300.4%) | $50.55 M(-52.4%) |
| Sept 2017 | - | $106.13 M(+218.5%) |
| June 2017 | - | $33.33 M(-39.3%) |
| Mar 2017 | - | $54.95 M(+335.1%) |
| Dec 2016 | $12.63 M(+721.5%) | $12.63 M(-3.7%) |
| Sept 2016 | - | $13.11 M(-230.1%) |
| June 2016 | - | -$10.08 M(-20.3%) |
| Mar 2016 | - | -$12.64 M(-922.7%) |
| Dec 2015 | $1.54 M(-95.2%) | $1.54 M(-92.3%) |
| Sept 2015 | - | $20.06 M(-53.7%) |
| June 2015 | - | $43.32 M(+122.1%) |
| Mar 2015 | - | $19.50 M(-39.1%) |
| Dec 2014 | $32.05 M(+19.3%) | $32.05 M(-62.4%) |
| Sept 2014 | - | $85.32 M(-8.6%) |
| June 2014 | - | $93.31 M(+323.3%) |
| Mar 2014 | - | $22.04 M(-18.0%) |
| Dec 2013 | $26.86 M(+8.5%) | $26.86 M(-20.2%) |
| Sept 2013 | - | $33.66 M(+56.0%) |
| June 2013 | - | $21.57 M(-10.4%) |
| Mar 2013 | - | $24.08 M(-2.7%) |
| Dec 2012 | $24.75 M(-6.8%) | $24.75 M(-27.2%) |
| Sept 2012 | - | $34.02 M(+31.1%) |
| June 2012 | - | $25.96 M(-29.4%) |
| Mar 2012 | - | $36.78 M(+38.5%) |
| Dec 2011 | $26.56 M(-55.3%) | $26.56 M(-35.4%) |
| Sept 2011 | - | $41.11 M(-29.0%) |
| June 2011 | - | $57.92 M(-26.4%) |
| Mar 2011 | - | $78.68 M(+32.4%) |
| Dec 2010 | $59.42 M(-19.5%) | $59.42 M(-14.5%) |
| Sept 2010 | - | $69.52 M(+7.5%) |
| June 2010 | - | $64.66 M(-9.8%) |
| Mar 2010 | - | $71.70 M(-2.8%) |
| Dec 2009 | $73.77 M | $73.77 M(+123.9%) |
| Sept 2009 | - | $32.95 M(-25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $43.99 M(-14.7%) |
| Mar 2009 | - | $51.57 M(-11.0%) |
| Dec 2008 | $57.92 M(-8.9%) | $57.92 M(-7.4%) |
| Sept 2008 | - | $62.55 M(+63.4%) |
| June 2008 | - | $38.27 M(-25.4%) |
| Mar 2008 | - | $51.31 M(-19.3%) |
| Dec 2007 | $63.59 M(+81.4%) | $63.59 M(-4.8%) |
| Sept 2007 | - | $66.83 M(+95.0%) |
| June 2007 | - | $34.27 M(+1.7%) |
| Mar 2007 | - | $33.71 M(-3.8%) |
| Dec 2006 | $35.06 M(-49.7%) | $35.06 M(-2.0%) |
| Sept 2006 | - | $35.75 M(-30.7%) |
| June 2006 | - | $51.56 M(-15.2%) |
| Mar 2006 | - | $60.79 M(-12.8%) |
| Dec 2005 | $69.72 M(+231.4%) | $69.72 M(+148.7%) |
| Sept 2005 | - | $28.03 M(-11.1%) |
| June 2005 | - | $31.53 M(-19.2%) |
| Mar 2005 | - | $39.02 M(+85.5%) |
| Dec 2004 | $21.04 M(+8.7%) | $21.04 M(+3.9%) |
| Sept 2004 | - | $20.26 M(-10.6%) |
| June 2004 | - | $22.65 M(-15.7%) |
| Mar 2004 | - | $26.86 M(+38.8%) |
| Dec 2003 | $19.36 M(-19.5%) | $19.36 M(+1.6%) |
| Sept 2003 | - | $19.04 M(-23.2%) |
| June 2003 | - | $24.79 M(+9.4%) |
| Mar 2003 | - | $22.67 M(-5.8%) |
| Dec 2002 | $24.06 M(-20.9%) | $24.06 M(-10.7%) |
| Sept 2002 | - | $26.95 M(+2.2%) |
| June 2002 | - | $26.37 M(-7.3%) |
| Mar 2002 | - | $28.44 M(-6.5%) |
| Dec 2001 | $30.42 M(+40.6%) | $30.42 M(-1.3%) |
| Sept 2001 | - | $30.83 M(+6.3%) |
| June 2001 | - | $29.00 M(-5.5%) |
| Mar 2001 | - | $30.69 M(+41.8%) |
| Dec 2000 | $21.64 M(-5.5%) | $21.64 M(-15.2%) |
| Sept 2000 | - | $25.52 M(-0.4%) |
| June 2000 | - | $25.63 M(-1.8%) |
| Mar 2000 | - | $26.09 M(+13.9%) |
| Dec 1999 | $22.90 M(+5.0%) | $22.90 M(+21.8%) |
| Sept 1999 | - | $18.80 M(+9.3%) |
| June 1999 | - | $17.20 M(-7.0%) |
| Mar 1999 | - | $18.50 M(-15.1%) |
| Dec 1998 | $21.80 M(+16.0%) | $21.80 M(+1.9%) |
| Sept 1998 | - | $21.40 M(+15.7%) |
| June 1998 | - | $18.50 M(-3.1%) |
| Mar 1998 | - | $19.10 M(+1.6%) |
| Dec 1997 | $18.80 M(-29.6%) | $18.80 M(-21.3%) |
| Sept 1997 | - | $23.90 M(-10.8%) |
| June 1997 | - | $26.80 M(+20.7%) |
| Mar 1997 | - | $22.20 M(-16.9%) |
| Dec 1996 | $26.70 M(+151.9%) | $26.70 M(-19.1%) |
| Sept 1996 | - | $33.00 M(+94.1%) |
| June 1996 | - | $17.00 M(+1.8%) |
| Mar 1996 | - | $16.70 M(+57.5%) |
| Dec 1995 | $10.60 M(+2.9%) | $10.60 M(-16.5%) |
| Sept 1995 | - | $12.70 M(-13.0%) |
| June 1995 | - | $14.60 M(+94.7%) |
| Mar 1995 | - | $7.50 M(-27.2%) |
| Dec 1994 | $10.30 M | $10.30 M(-16.3%) |
| Sept 1994 | - | $12.30 M(+3.4%) |
| June 1994 | - | $11.90 M(+5.3%) |
| Mar 1994 | - | $11.30 M |
FAQ
- What is BioCryst Pharmaceuticals annual working capital?
- What is the all time high annual working capital for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly working capital year-on-year change?
What is BioCryst Pharmaceuticals annual working capital?
The current annual working capital of BCRX is $345.98 M
What is the all time high annual working capital for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual working capital is $462.42 M
What is BioCryst Pharmaceuticals quarterly working capital?
The current quarterly working capital of BCRX is $273.56 M
What is the all time high quarterly working capital for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly working capital is $462.42 M
What is BioCryst Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, BCRX quarterly working capital has changed by -$72.42 M (-20.93%)